AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildato M 500mg/50mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Exito Pharma

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildato M 500mg/50mg Tablet SR

Combinazione M 500mg/50mg Extended-Release Tablets effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. Combinazione M may be prescribed independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized, factoring in your health status, glycemic control, and existing medications. Ingesting it with food minimizes gastrointestinal discomfort. Consistent daily dosing maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Effective blood sugar regulation prevents future complications. Continued commitment to your prescribed diet and exercise regimen is crucial. Lifestyle choices significantly impact diabetes management. Commonly reported adverse effects include diarrhea, nausea, vomiting, dyspepsia, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia, especially when used with insulin or sulfonylureas, is a potential side effect; familiarity with its symptoms and management is essential. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before initiating treatment. Potential drug interactions necessitate disclosure of all current medications to ensure safety. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Your doctor will monitor renal function and blood glucose levels throughout your treatment.

Primary Ingredients of Vildato M 500mg/50mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Vildato M 500mg/50mg Tablet SR

Managing type 2 diabetes

Major Benefits of Vildato M 500mg/50mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Consume Vildato M 500mg/50mg Sustained-Release tablets with a meal.

Common Side effects of Vildato M 500mg/50mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildato M 500mg/50mg Tablet SR:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Vildato M 500mg/50mg Sustained-Release tablets with a meal.

How Vildato M 500mg/50mg Tablet SR works:

Vildato M 500mg/50mg extended-release tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Vildato M 500mg/50mg SR tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Vildato M 500mg/50mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Vildato M 500mg/50mg tablets are likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when taking Vildato M 500mg/50mg sustained-release tablets. Dosage modification of Vildato M 500mg/50mg sustained-release tablets may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

The extended-release Vildato M 500mg/50mg tablet may pose significant risks for individuals with hepatic impairment and its use should be avoided. A physician's consultation is recommended.

What if you forget to take Vildato M 500mg/50mg Tablet SR :

Should you forget a Vildato M 500mg/50mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vildato M 500mg/50mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildato M 500mg/50mg Tablet SR

Vildato M 500mg/50mg SR tablets rarely cause hypoglycemia by themselves; however, insufficient caloric intake while using this medication may lead to low blood sugar. Symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may indicate hypoglycemia, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildato M 500mg/50mg Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without first talking to your doctor.
Vildato M 500mg/50mg Tablet SR is contraindicated in patients with allergies to its components or excipients. It should also not be used by individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildato M 500mg/50mg SR tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildato M 500mg/50mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Vildato M 500mg/50mg Tablet SR and seek immediate medical attention.
Prolonged use of Vildato M 500mg/50mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Vildato M 500mg/50mg SR tablets as directed by your doctor is safe. However, even with correct usage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent issues to your doctor.
Vildato M 500mg/50mg Tabl...
128
MRP 149
13% off